Literature DB >> 2178362

Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo.

W Wouters1, R De Coster, J van Dun, M D Krekels, A Dillen, A Raeymaekers, E Freyne, J Van Gelder, G Sanz, M Venet.   

Abstract

R76713 (6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-methyl-1H- benzotriazole) is a selective, non-steroidal aromatase inhibitor containing an asymmetric carbon atom. In this paper, we compare the effects of R76713 (racemate) with its enantiomers R83839 (the levo-isomer) and R83842 (the dextro-isomer) on steroid biosynthesis in rat cells in vitro and in the rat in vivo. In rat granulosa cells, aromatase activity was inhibited by 50% at concentrations of 0.93 nM of R76713, 240 nM of R83839 and 0.44 nM of R83842, revealing a 545-fold difference in activity between both enantiomers. Up to 1 microM, none of the compounds had any effect on steroid production in primary cultures of rat testicular cells. Above this concentration all three compounds showed a similar slight inhibition of androgen synthesis with a concomitant increase in the precursor progestins, indicative for some effect on the 17-hydroxylase/17,20-lyase enzyme. In rat adrenal cells none of the compounds showed any effect on corticosterone synthesis. At concentrations above 1 microM there was an increase in the levels of 11-deoxycorticosterone pointing towards an inhibition of the 11-hydroxylase enzyme. This increase was more pronounced for R83839 than for R76713 and R83842. In vivo, in PMSG-primed rats, R83842 reduced plasma estradiol by 50%. 2 h after oral administration of 0.0034 mg/kg, whereas 0.011 mg/kg of R76713 and 0.25 mg/kg of R83839 were needed to obtain the same result. Oral administration of up to 20 mg/kg of the compounds did not significantly affect plasma levels of adrenal steroids in LHRH/ACTH-injected rats. Plasma testosterone was lowered at 10 and 20 mg/kg of R83842 and at the highest dose (20 mg/kg) of R76713 and R83839. In conclusion, the present study shows that the aromatase inhibitory activity of R76713 resides almost exclusively in its dextro-isomer R83842. R83842 exhibits a specificity for aromatase as compared to other enzymes involved in steroid biosynthesis of at least a 1000-fold in vitro as well as in vivo. This confirms the extreme selectivity previously found for the racemate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178362     DOI: 10.1016/0960-0760(90)90464-v

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  Aromatization of androgens is important for skeletal maintenance of aged male rats.

Authors:  D Vanderschueren; E Van Herck; R De Coster; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 2.  How technical progress reshaped behavioral neuroendocrinology during the last 50 years… and some methodological remarks.

Authors:  Jacques Balthazart
Journal:  Horm Behav       Date:  2020-01-13       Impact factor: 3.587

Review 3.  Vorozole.

Authors:  L R Wiseman; C M Spencer
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

4.  Human and quail aromatase activity is rapidly and reversibly inhibited by phosphorylating conditions.

Authors:  Thierry D Charlier; Nobuhiro Harada; Jacques Balthazart; Charlotte A Cornil
Journal:  Endocrinology       Date:  2011-09-13       Impact factor: 4.736

Review 5.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

6.  Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase.

Authors:  Sung Won Kim; Anat Biegon; Zachary E Katsamanis; Carolin W Ehrlich; Jacob M Hooker; Colleen Shea; Lisa Muench; Youwen Xu; Payton King; Pauline Carter; David L Alexoff; Joanna S Fowler
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

Review 7.  Vorozole, a specific non-steroidal aromatase inhibitor.

Authors:  W Wouters; E Snoeck; R De Coster
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.